{
    "clinical_study": {
        "@rank": "156535", 
        "arm_group": {
            "arm_group_label": "ICD System Therapy", 
            "description": "Patients with a ProMRI ICD System"
        }, 
        "brief_summary": {
            "textblock": "The objective of the ProMRI Study is to demonstrate the clinical safety of the ProMRI ICD\n      System when used under specific MRI conditions."
        }, 
        "brief_title": "ProMRI Study of the Iforia ICD System (Phase C)", 
        "completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Implantable Cardioverter-Defibrillator With Magnetic Resonance Imaging", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        The following initial inclusion criteria must be met for a subject to be enrolled and\n        considered for the MRI-procedure:\n\n          -  Age greater than or equal to 18 years\n\n          -  Able and willing to complete MRI testing\n\n          -  Able to provide written informed consent\n\n          -  Available for follow-up visit at the study site\n\n          -  Implanted with an ICD System consisting only of an Iforia DR-T and Linoxsmart S 65 /\n             Linoxsmart SD 65/18 with Setrox S 53 atrial lead or Iforia VR-T DX and Linoxsmart S\n             DX 65/15 or Linoxsmart S DX 65/17.\n\n          -  ICD implanted pectorally\n\n          -  All ICD system components implanted, repositioned, or exchanged at least 5 weeks\n             prior to enrollment\n\n          -  Underlying rhythm identifiable during sensing test\n\n          -  All pacing thresholds are measureable and are less than or equal to 2.0 V @ 0.4 ms\n             (Criterion does not apply to atrial pacing threshold for subjects with an Iforia DR-T\n             that have AF and are permanently programmed to VVI and for subjects with an Iforia\n             VR-T DX)\n\n          -  Ventricular sensing is measurable and >6.5mV\n\n          -  Absence of phrenic nerve stimulation at 5.0V and 1.0 ms\n\n          -  Pacing impedance is between 200 and 1500 ohm\n\n          -  Shock Impedance is between 30 and 90 ohm\n\n          -  Able and willing to use the CardioMessenger II\n\n        At the pre-MRI procedure, the following procedure-related criteria must be met for the\n        subject to undergo the MRI scan:\n\n          -  Absence of phrenic nerve stimulation at 5.0V @ 1.0 ms\n\n          -  /pacing threshold at Pre-MRI follow-up - pacing threshold at baseline/ \u2264 0.5 V (ICD\n             Lead Only)\n\n          -  All pacing thresholds are measureable and are less than or equal to 2.0 V @ 0.4 ms\n             (Criterion does not apply to atrial pacing threshold for subjects with an Iforia DR-T\n             that have AF and are permanently programmed to VVI and for subjects with an Iforia\n             VR-T DX.)\n\n          -  Ventricular sensing is measurable and >6.5mV\n\n          -  The ICD system has been implanted for at least six weeks.\n\n          -  Subject did not have an ICD or lead explant, exchange or reposition in the previous 6\n             weeks.\n\n          -  All lead pacing impedances are between 200 and 1500 ohm\n\n          -  Shock impedance is between 30 and 90 ohm\n\n          -  Battery status is at least 30% of capacity"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "The patients selected for participation should be from the investigators' general patient\n        population according to the inclusion and exclusion criteria."
            }
        }, 
        "enrollment": {
            "#text": "172", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 24, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02096692", 
            "org_study_id": "G120226 (Phase C)"
        }, 
        "intervention": [
            {
                "arm_group_label": "ICD System Therapy", 
                "description": "Tachycardia Fast Heart Beat", 
                "intervention_name": "Patients with a ProMRI ICD System", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "ICD System Therapy", 
                "description": "MRI scan of heart/chest or thoracic spine", 
                "intervention_name": "Magnetic Resonance Imaging (MRI) scan", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "May 23, 2014", 
        "number_of_groups": "1", 
        "overall_contact": {
            "email": "michelle.montalto@biotronik.com", 
            "last_name": "Michelle Montalto", 
            "phone": "1-503-451-8046"
        }, 
        "overall_contact_backup": {
            "email": "justin.michalski@biotronik.com", 
            "last_name": "Justin Michalski, MS", 
            "phone": "1-503-451-8049"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "MRI and ICD system related Serious Adverse Device Effect (SADE) free rate", 
                "safety_issue": "Yes", 
                "time_frame": "1 Month"
            }, 
            {
                "description": "Evaluate the percentage of ICD leads with a ventricular pacing threshold increase between the Pre-MRI and one-month post-MRI follow-up.", 
                "measure": "Ventricular Pacing Threshold Rise", 
                "safety_issue": "Yes", 
                "time_frame": "1 Month"
            }, 
            {
                "description": "Evaluate the percentage of subjects who experience R-wave attenuation between the Pre-MRI and one-month post-MRI follow-up.", 
                "measure": "R-wave Sensing Attenuation", 
                "safety_issue": "Yes", 
                "time_frame": "1 Month"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02096692"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Biotronik, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Biotronik, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}